14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 26, 2024 Buy 103 600 Webster Stephen W Stock Option (Right to Buy)
Apr 26, 2024 Buy 0 Webster Stephen W Common Stock
Feb 01, 2024 Buy 35 000 Hawryluk Matthew Common Stock
Feb 01, 2024 Buy 180 000 Hawryluk Matthew Stock Option (Right to Buy)
Feb 01, 2024 Buy 40 000 Jones Erin Common Stock
Feb 01, 2024 Buy 235 000 Jones Erin Stock Option (Right to Buy)
Feb 01, 2024 Buy 35 000 Economides Vassiliki Common Stock
Feb 01, 2024 Buy 215 000 Economides Vassiliki Stock Option (Right to Buy)
Feb 01, 2024 Buy 40 000 Jooss Karin Common Stock
Feb 01, 2024 Buy 235 000 Jooss Karin Stock Option (Right to Buy)
Feb 01, 2024 Buy 18 000 Cho James Common Stock
Feb 01, 2024 Buy 109 000 Cho James Stock Option (Right to Buy)
Feb 01, 2024 Buy 105 000 Allen Andrew R Common Stock
Feb 01, 2024 Buy 615 000 Allen Andrew R Stock Option (Right to Buy)
Jun 16, 2023 Buy 51 800 Corey Lawrence Stock Option (Right to Buy)
Jun 16, 2023 Buy 51 800 Fisher Clare Stock Option (Right to Buy)
Jun 16, 2023 Buy 51 800 Jones Elaine V Stock Option (Right to Buy)
Jun 16, 2023 Buy 51 800 Rizvi Naiyer Stock Option (Right to Buy)
Jun 16, 2023 Buy 51 800 Krognes Steve E. Stock Option (Right to Buy)
Jun 16, 2023 Buy 51 800 Agarwal Shefali Stock Option (Right to Buy)
May 23, 2023 Buy 12 000 Economides Vassiliki Common Stock
Feb 02, 2023 Buy 252 763 Jooss Karin Common Stock
Feb 02, 2023 Buy 252 845 Jones Erin Common Stock
Feb 02, 2023 Buy 191 771 Hawryluk Matthew Common Stock
Feb 02, 2023 Buy 179 058 Economides Vassiliki Common Stock
Feb 02, 2023 Buy 64 515 Cho James Common Stock
Feb 02, 2023 Buy 738 550 Allen Andrew R Common Stock
Aug 12, 2022 Buy 38 000 Corey Lawrence Stock Option (Right to Buy)
Aug 12, 2022 Buy 0 Corey Lawrence
Jun 17, 2022 Buy 19 000 Rizvi Naiyer Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Krognes Steve E. Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Krognes Steve E. Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Jones Elaine V Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Jones Elaine V Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Heyman Richard A. Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Heyman Richard A. Stock Option (Right to Buy)
Jun 17, 2022 Buy 8 693 Fisher Clare Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Agarwal Shefali Stock Option (Right to Buy)
Jun 17, 2022 Buy 19 000 Agarwal Shefali Stock Option (Right to Buy)
Jan 31, 2022 Buy 115 440 Thompson Rahsaan Stock Option (Right to Buy)
Jan 31, 2022 Buy 19 240 Thompson Rahsaan Common Stock
Jan 31, 2022 Buy 27 600 Jooss Karin Common Stock
Jan 31, 2022 Buy 165 600 Jooss Karin Stock Option (Right to Buy)
Jan 31, 2022 Buy 163 013 Jones Erin Stock Option (Right to Buy)
Jan 31, 2022 Buy 27 169 Jones Erin Common Stock
Jan 31, 2022 Buy 129 675 Hawryluk Matthew Stock Option (Right to Buy)
Jan 31, 2022 Buy 21 612 Hawryluk Matthew Common Stock
Jan 31, 2022 Buy 138 000 Economides Vassiliki Stock Option (Right to Buy)
Jan 31, 2022 Buy 23 000 Economides Vassiliki Common Stock
Jan 31, 2022 Buy 4 400 Cho James Common Stock
Jan 31, 2022 Buy 26 300 Cho James Stock Option (Right to Buy)
Jan 31, 2022 Buy 410 000 Allen Andrew R Stock Option (Right to Buy)
Jan 31, 2022 Buy 70 000 Allen Andrew R Common Stock
Jan 01, 2022 Buy 38 000 Fisher Clare Stock Option (Right to Buy)
Jan 01, 2022 Buy 0 Fisher Clare
Dec 01, 2021 Buy 1 000 Jones Erin Common Stock
Dec 01, 2021 Sell 1 000 Jones Erin Common Stock
Dec 01, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Nov 01, 2021 Buy 1 000 Jones Erin Common Stock
Nov 01, 2021 Sell 1 000 Jones Erin Common Stock
Nov 01, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Nov 01, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Nov 01, 2021 Buy 1 000 Jones Erin Common Stock
Nov 01, 2021 Sell 1 000 Jones Erin Common Stock
Oct 04, 2021 Buy 1 000 Jones Erin Common Stock
Oct 04, 2021 Sell 1 000 Jones Erin Common Stock
Oct 04, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Oct 04, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Oct 01, 2021 Sell 1 000 Jones Erin Common Stock
Oct 01, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Oct 01, 2021 Sell 1 000 Jones Erin Stock Option (Right to Buy)
Sep 08, 2021 Buy 2 000 Jones Erin Common Stock
Sep 08, 2021 Sell 2 000 Jones Erin Common Stock
Sep 08, 2021 Sell 2 000 Jones Erin Stock Option (Right to Buy)
Jun 18, 2021 Buy 937 Agarwal Shefali Stock Option (Right to Buy)
Jun 18, 2021 Buy 937 Rizvi Naiyer Stock Option (Right to Buy)
Jun 18, 2021 Buy 19 000 Li Judith Stock Option (Right to Buy)
Jun 18, 2021 Buy 19 000 Krognes Steve E. Stock Option (Right to Buy)
Jun 18, 2021 Buy 19 000 Jones Elaine V Stock Option (Right to Buy)
Jun 18, 2021 Buy 19 000 Heyman Richard A. Stock Option (Right to Buy)
Jun 01, 2021 Buy 38 000 Agarwal Shefali Stock Option (Right to Buy)
Jun 01, 2021 Buy 38 000 Rizvi Naiyer Stock Option (Right to Buy)
Jun 01, 2021 Buy 0 Agarwal Shefali
Jun 01, 2021 Buy 4 347 Rizvi Naiyer Stock Option (Right to Buy)
Jun 01, 2021 Buy 10 000 Rizvi Naiyer Stock Option (Right to Buy)
Jun 01, 2021 Buy 7 500 Rizvi Naiyer Stock Option (Right to Buy)
Mar 08, 2021 Buy 50 724 Yelensky Roman Common Stock
Mar 08, 2021 Sell 50 724 Yelensky Roman Stock Option (Right to Buy)
Mar 08, 2021 Buy 25 000 Cho James Stock Option (Right to Buy)
Jan 27, 2021 Buy 0 Cho James Common Stock
Jan 27, 2021 Buy 40 000 Cho James Stock Option (Right to Buy)
Jan 19, 2021 Sell 10 000 Yelensky Roman Common Stock
Jan 07, 2021 Buy 25 900 Jones Erin Common Stock
Jan 07, 2021 Buy 28 000 Yabannavar Vijay Common Stock
Jan 07, 2021 Buy 29 700 Rousseau Raphael Common Stock
Jan 07, 2021 Buy 27 400 Yelensky Roman Common Stock
Jan 07, 2021 Buy 25 500 Thompson Rahsaan Common Stock
Jan 07, 2021 Buy 27 900 Jooss Karin Common Stock
Jan 07, 2021 Buy 19 600 Hawryluk Matthew Common Stock
Jan 07, 2021 Buy 48 200 Allen Andrew R Common Stock
INSIDER POWER
98.628
Last 100 transactions
Buy: 6 094 289 | Sell: 76 724 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 98.628.

In total, the insiders bought 6 094 289 and sold 76 724 GRTS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Gritstone Oncology Inc.

Gritstone Oncology. Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-she... GRTS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT